Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/1/2021
NMPA Issues Technical Guidelines Related to Companion Diagnostic Reag...
12/1/2021
Genetron and AstraZeneca China Enter Co-Development Agreement for MR...
11/30/2021
JPO Releases Final Tender Outcome of the 6th VBP
10/15/2021
Gan & Lee Concludes Phase 3 Studies of Biosimilar Insulin Glargine (G...
10/15/2021
Adocia's Partner Tonghua Dongbao Cleared to Start Ultra-Rapid Insulin ...
10/14/2021
Dr. Reddy's Becomes the First Indian Company to Launch An Anticancer i...
10/11/2021
Impact of the 2020 China Diabetes Society Guideline on the Prevalence ...
9/15/2021
Hua Medicine and Sinopharm Enter Supply Chain Strategic Cooperation
9/14/2021
CDE Issues the Technical Guidelines for Clinical Trial of Improvement ...
9/7/2021
NMPA Announces Package Insert Revision of Diammonium Glycyrrhizinate F...
8/23/2021
BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
8/20/2021
Novartis Receives Approval for Lucentis and Launches Galvus in China
8/3/2021
India Initiates Anti-dumping Probe against Chemical from China for Ato...
6/25/2021
Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...
4/23/2021
Hua Medicine Files Chinese NDA for Dorzagliatin
4/14/2021
BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...
2/23/2021
Indian Pharma Firms Go Local Seeking to End Reliance on China
12/28/2020
Chinese Hypertension Prevalence Up 27.5% in the Past Five Years
12/24/2020
Obesity Continues to Surge in China Due to Unhealthy Lifestyles
12/10/2020
China vs. India: the Fight for Pharma Supremacy
11/11/2020
Facing The Chinese Challenge – Are Indian Pharmaceutical Companies Up...
10/29/2020
China Sets Goal to Reduce Childhood Obesity by 70% in the Next Decade
10/28/2020
India's Balaxi Pharma to Establish Sourcing Arm in China
10/22/2020
Fosun-owned Gland Pharma Granted Approval for Indian IPO
10/7/2020
India Probes Alleged API Dumping by Chinese Companies
9/25/2020
BioDuro and Sundia Tie Up to Become Industry Leading CRDMO
9/2/2020
CDE Solicits Comments on the Draft Guidelines for Clinical Pharmacolog...
8/18/2020
Bayer and Hua Medicine Enter Partnership for Novel Diabetes Drug Dorza...
8/7/2020
WSJ: Drug Industry's China Habit Will Take Time to Kick
7/15/2020
China's Fosun Pulls Back from Healthcare Deals Worth $300 million in I...
Page:
5
/
18
Total number of articles:
524
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit